收藏切换
Pre-treatment and acquired drug resistance characteristics among HIV-1-infected individuals in Hebei Province, China
收藏切换
PDF
Meng LIU, Ying-ying WANG, Ning AN, Guang-yi BAI, Yan LI, Xue-ang XU, Yu-qi ZHANG, Xin-li LU
Modern Preventive Medicine | 2025, 52(15) : 2860 - 2865
Less
收藏切换
Modern Preventive Medicine | 2025, 52(15): 2860-2865
Disease Control and Prevention
Pre-treatment and acquired drug resistance characteristics among HIV-1-infected individuals in Hebei Province, China
Full
Meng LIU, Ying-ying WANG, Ning AN, Guang-yi BAI, Yan LI, Xue-ang XU, Yu-qi ZHANG, Xin-li LU
Affiliations
  • Department of STD and AIDS Research, Hebei Provincial Center for Disease Control and Prevention, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Shijiazhuang, Hebei Province 050021, China
Published: 2025-08-10 doi: 10.20043/j.cnki.MPM.202503276
Outline
收藏切换
Objective

To investigate the epidemiology and influencing factors of pre-treatment drug resistance (PDR) and acquired drug resistance(ADR) in Hebei Province.

Methods

Plasma samples were collected from HIV-1-infected individuals who were ART-naive or experiencing ART failure in Hebei Province from January 2022 to December 2023 to determine drug resistance profiles. Multivariate logistic regression was used to analyze the influencing factors of drug resistance.

Results

The overall prevalence of PDR were 9.19%, showing a moderate prevalence trend. The overall prevalence of ADR was 46.71%,presenting a high level of drug resistance and the phenomenon of cross drug resistance. Multivariate logistic regression analysis showed that start ART more than one year after diagnosis (OR=3.007, 95% CI: 1.185-7.633) and being infected with subtypes other than CRF07_BC, subtype B, and URFs (OR=3.227, 95% CI: 1.043-9.991) were risk factors for PDR. Non-farmer occupation(OR=1.787, 95% CI: 1.129-2.830) and 3-5 years treatment duration(OR=2.440, 95% CI: 1.422-4.185) were risk factors for ADR, while CD4+T-cell counts between 200-500 cells/μl (OR=0.382, 95% CI: 0.236-0.618) and above 500 cells/μl(OR=0.158, 95% CI: 0.083-0.299), second-line regimens containing LPV/r or BIC (OR=0.229, 95% CI: 0.083-0.629; OR=0.064,95% CI: 0.008-0.534), and CRF07_BC(OR=0.398, 95% CI: 0.245-0.647) were protective factors for ADR.

Conclusion

Monitoring of local PDR and ADR should be strengthened to know about the situation of drug resistance as early as possible, and targeted interventions should be taken to reduce the spread of HIV-1 drug-resistant strains.

HIV-1  /  Pre-treatment drug resistance  /  Acquired drug resistance  /  Subtype
Meng LIU, Ying-ying WANG, Ning AN, Guang-yi BAI, Yan LI, Xue-ang XU, Yu-qi ZHANG, Xin-li LU. Pre-treatment and acquired drug resistance characteristics among HIV-1-infected individuals in Hebei Province, China[J]. Modern Preventive Medicine, 2025 , 52 (15) : 2860 -2865 . DOI: 10.20043/j.cnki.MPM.202503276
Year 2025 volume 52 Issue 15
PDF
57
24
Cite this Article
BibTeX
Article Info
doi: 10.20043/j.cnki.MPM.202503276
  • Receive Date:2025-03-15
  • Online Date:2026-03-16
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-03-15
Funding
Affiliations
    Department of STD and AIDS Research, Hebei Provincial Center for Disease Control and Prevention, Hebei Key Laboratory of Pathogen and Epidemiology of Infectious Disease, Shijiazhuang, Hebei Province 050021, China
References
Share
https://castjournals.cast.org.cn/joweb/xdyfyx/EN/10.20043/j.cnki.MPM.202503276
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT